Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women
- PMID: 7583563
- DOI: 10.1161/01.atv.15.11.1839
Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women
Abstract
VLDL1, VLDL2, IDL, and LDL and its subfractions (LDL-I, LDL-II, and LDL-III) were quantified in 304 normolipemic subjects together with postheparin plasma lipase activities, waist/hip ratio, fasting insulin, and glucose. Concentrations of VLDL1 and VLDL2 rose as plasma triglycerides (TGs) increased across the normal range, but the association of plasma TGs with VLDL1 showed a steeper slope than that of VLDL2 (P < .001). Plasma TG level was the most important determination of LDL subfraction distribution. The least dense species, LDL-I, decreased as the level of this plasma lipid rose in the population. LDL-II in both men and women exhibited a positive association with plasma TG level in the range 0.5 to 1.3 mmol/L, increasing from about 100 to 200 mg/dL. In contrast, within this TG range the LDL-III concentration was low (approximately equal to 30 mg/dL) and changed little. As plasma TGs rose from 1.3 to 3.0 mmol/L there was a significant fall in LDL-II concentration in men (r = .45, P < .001) but not in women (r = .1, NS). Conversely, above the TG threshold of 1.3 mmol/L there was a steeper rise in LDL-III concentrations in men than in women (P < .001); 42% of the men had and LDL-III in the range associated with high risk of heart disease ( > 100 mg lipoprotein/dL plasma) compared with only 17% of the women. Other influences on the LDL subfraction profile were the activities of lipases and parameters indicative of the presence of insulin resistance. Men on average had twice the hepatic lipase activity of women. This enzyme was not strongly associated with variation in the LDL subfraction profile in men, but in women it was correlated with LDL-III (r = 39, P = .001) and remained a significant predictor in multivariate analysis. Increased waist/hip ratio, fasting insulin, and glucose were correlated negatively with LDL-I and positively with LDL-III, primarily, at least in the case of LDL-III, through raising plasma TGs. On the basis of these cross-sectional observations we postulate the following model for the generation of LDL-III. Subjects develop elevated levels of large TG-rich VLDL1 for a number of reasons, including failure of insulin action. The increase in the concentration of VLDL1 expands the plasma TG pool, and this, via the action of cholesteryl ester transfer protein (which facilitates neutral lipid exchange between lipoprotein particles), promotes the net transfer of TGs into LDL-II, the major LDL species.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.J Clin Endocrinol Metab. 1997 Aug;82(8):2483-91. doi: 10.1210/jcem.82.8.4126. J Clin Endocrinol Metab. 1997. PMID: 9253322
-
Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.Atherosclerosis. 1993 Jan 4;98(1):33-49. doi: 10.1016/0021-9150(93)90221-f. Atherosclerosis. 1993. PMID: 8457249
-
Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis.Obstet Gynecol. 1997 Mar;89(3):403-8. doi: 10.1016/S0029-7844(96)00514-5. Obstet Gynecol. 1997. PMID: 9052594
-
In vivo studies of VLDL metabolism and LDL heterogeneity.Eur Heart J. 1998 Jul;19 Suppl H:H7-10. Eur Heart J. 1998. PMID: 9717058 Review.
-
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.Am J Cardiol. 2002 Oct 17;90(8A):30i-47i. doi: 10.1016/s0002-9149(02)02749-2. Am J Cardiol. 2002. PMID: 12419479 Review.
Cited by
-
Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy.Vasc Health Risk Manag. 2012;8:39-44. doi: 10.2147/VHRM.S22601. Epub 2012 Jan 25. Vasc Health Risk Manag. 2012. PMID: 22323895 Free PMC article. Clinical Trial.
-
Diabetic dyslipidaemia: from basic research to clinical practice.Diabetologia. 2003 Jun;46(6):733-49. doi: 10.1007/s00125-003-1111-y. Epub 2003 May 28. Diabetologia. 2003. PMID: 12774165 Review.
-
The physiology of lipoproteins.J Nucl Cardiol. 2002 Nov-Dec;9(6):638-49. doi: 10.1067/mnc.2002.128959. J Nucl Cardiol. 2002. PMID: 12466789 Review.
-
Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes.J Diabetes Investig. 2025 Mar;16(3):370-383. doi: 10.1111/jdi.14398. Epub 2025 Jan 7. J Diabetes Investig. 2025. PMID: 39778086 Free PMC article. Review.
-
Sex-Related Differences in the Associations between Adiponectin and Serum Lipoproteins in Healthy Subjects and Patients with Metabolic Syndrome.Biomedicines. 2024 Sep 1;12(9):1972. doi: 10.3390/biomedicines12091972. Biomedicines. 2024. PMID: 39335486 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous